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Abstract
Members of the annexin protein family interact with members of the S100 protein family thereby forming heterotetramers
in which an S100 homodimer crossbridges two copies of the pertinent annexin. Previous work has shown that S100A1 and
S100B bind annexin VI in a Ca2-dependent manner and that annexin VI, but not annexin V, blocks the inhibitory effect of
S100A1 and S100B on intermediate filament assembly. We show here that both halves of annexin VI (i.e., the N-terminal half
or annexin VI-a and the C-terminal half or annexin VI-b) bind individual S100s on unique sites and that annexin VI-b, but
not annexin VI-a, blocks the ability of S100A1 and S100B to inhibit intermediate filament assembly. We also show that the
C-terminal extension of S100A1 (and, by analogy, S100B), that was previously demonstrated to be critical for S100A1 and
S100B binding to several target proteins including intermediate filament subunits, is not part of the S100 surface implicated
in the recognition of annexin VI, annexin VI-a, or annexin VI-b. Evaluation of functional properties with a liposome stability
and a calcium influx assay reveals the ability of both S100 proteins to permeabilize the membrane bilayer in a similar fashion
like annexins. When tested in combinations with different annexin proteins both S100 proteins mostly lead to a decrease in
the calcium influx activity although not all annexin/S100 combinations behave in the same manner. Latter observation
supports the hypothesis that the S100-annexin interactions differ mechanistically depending on the particular protein
partners. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Annexins are members of a multigenic family of
Ca2-dependent phospholipid-, membrane- and cyto-
skeleton-binding proteins that have been implicated
in the regulation of the in£ammatory response, the
structural organization of membranes, exo- and en-
docytosis, ion £ux across membranes, and blood co-
agulation [1,2]. Individual annexins are characterized
by a common structural motif in which an N-termi-
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nal domain of variable sequence and length is fol-
lowed by a core domain made of four conserved
repeat units (eight in the case of annexin VI). In
turn, each repeat unit is made of ¢ve homologous
amphiphilic helices organized to form a globular
structure (a four-helix bundle with the ¢fth helix
perpendicular to it). It is suggested that the N-termi-
nal domain speci¢es the biological role of individual
annexins, whereas the core domain is responsible for
annexin interaction with acidic phospholipids and F-
actin. Crystal structure determinations indicate that
the four repeat units of the annexin core domain are
arranged so as to limit an internal hydrophilic hole,
that each annexin molecule shows a convex surface
through which it interacts with phospholipids and a
concave surface on the opposite side, and that the N-
terminal domain is found on the concave side of the
molecule [3].
S100 proteins are members of a multigenic family
of low molecular weight (Mr 9^13), Ca2-modulated
proteins of the EF-hand type that have been impli-
cated in the regulation of protein phosphorylation,
the dynamics of cytoskeleton constituents, enzyme
activities, Ca2 homeostasis, the cell cycle, and tran-
scription factors [4^6]. The most prominent feature
of any S100 protein is the presence of two EF-hand
(helix-loop-helix) motifs, corresponding to two Ca2-
binding sites, i.e. site I characterized by a low a⁄nity
for Ca2, and site II characterized by a higher a⁄n-
ity for Ca2. The least conserved regions in S100
members are the hinge region that connects the two
EF-hand sites, and the C-terminal extension, both of
which have a role in the interactions of S100 mem-
bers with their targets. There is evidence that most,
but not all, S100 proteins exist as homodimers (and,
in some cases, heterodimers), in which the two
monomers are antiparallelly packed [7^15]. Within
each monomer of an S100 dimer, the surface de¢ned
by residues in the hinge region, helices III and IV,
and the C-terminal extension is exposed to solvent
upon Ca2 binding. Accordingly, residues in the
above mentioned regions as well as residues in helix
II have been shown to participate in the recognition
of a number of target proteins by S100A1, S100B,
S100A10 and S100A11 [15^23]. It is also suggested
that the N-terminal helix (helix I) of the other mono-
mer of the dimer contributes to the formation of the
binding surface on each side of the dimer [15,19].
Interestingly, some annexins form complexes with
some S100 proteins. The prototype of these com-
plexes is the (annexin II-S100A10)2 heterotetramer,
in which an S100A10 homodimer crosslinks two cop-
ies of annexin II ([15], and Refs. therein). The asso-
ciation of S100A10 with annexin II is Ca2-inde-
pendent and of high (in the nanomolar range)
a⁄nity, and mediated by the N-terminal domain of
annexin II [15]. In other cases, the interaction be-
tween an annexin and an S100 protein was shown
to be Ca2-dependent and characterized by an a⁄n-
ity in the submicromolar-micromolar range [16,23^
27]. Thus, annexin I was shown to interact with
S100A11, annexin II with S100B, annexin XI with
S100A6, and annexins V and VI with S100A1 and
S100B. In several instances, functional correlates of
this heterocomplex formation were reported. For ex-
ample, binding of S100A10 or S100B causes inhibi-
tion of annexin II phosphorylation [27^29]; binding
of S100A10 to annexin II causes translocation of
annexin II onto membranes [30^33] and strongly en-
hances the annexin II ability to bundle F-actin [34],
to stimulate chroma⁄n granule aggregation and
secretion [35], and to rescue the assembly properties
of glial ¢brillary acidic protein (GFAP) at alkaline
pH values [36]; binding of S100A11 causes inhibi-
tion of annexin I phosphorylation [16,21] and, pos-
sibly, regulates the annexin I association with mem-
branes [37]; binding of annexin VI, but not annexin
V, to S100A1 and S100B blocks the ability of these
two proteins to inhibit the GFAP and desmin assem-
blies into their respective intermediate ¢laments (IFs)
[24].
Whereas GFAP, desmin, tubulin, a p53 peptide,
and the S100B and S100A1 inhibitory peptide,
TRTK-12, appeared to compete for the same site
on S100A1 and S100B [20,38], no major competition
between annexin VI and GFAP, desmin, and TRTK-
12 could be documented, although occupation of the
GFAP/desmin/TRTK-12 site on S100A1 and S100B
appeared to perturb the annexin VI site and vice
versa [24]. We hypothesized that the ability of annex-
in VI to block the capacity of S100A1 and S100B to
inhibit the GFAP and desmin assemblies in the ab-
sence of any obvious competition might depend on
annexin VI binding to a relatively large surface of
S100A1 and S100B not comprising their C-terminal
extension [24]. This mode of interaction could be
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envisaged given the size of annexin VI (MrW72). In
the present work we analyzed some aspects of the
annexin VI-S100A1 and S100B interaction to get in-
formation on which lobe of annexin VI is implicated
in the S100A1 and S100B binding as well as on the
role, if any, of the S100A1 and S100B C-terminal
extension in this interaction.
2. Materials and methods
2.1. Materials
S100B and S100A1 were puri¢ed from bovine
brain and porcine heart, respectively, as reported
[39,40]. Recombinant S100A1 or a truncated form
of S100A1 lacking the last six residues (Phe88-
Ser93) (S100A1v88^93) was expressed in the Esche-
richia coli strain BL21 (DE 3) pLysS (Novagen)
transformed with an expression plasmid containing
the human S100A1 gene [18] and puri¢ed from bac-
teria extracts as described [39]. S100A1 and
S100A1v88^93 constructs were kindly supplied by
V. Gerke (Mu«nster, Germany). GFAP was puri¢ed
from bovine spinal cord [41]. Recombinant S100B
was expressed in E. coli BL21 using the S100B ex-
pression vector VUSB-1 plasmid containing the bo-
vine brain S100B sequence [42], and puri¢ed as re-
ported [39]. Recombinant human annexins V, VI, VI-
a and VI-b were expressed and puri¢ed as described
earlier [43,44]. Annexin VI-a was constructed as
AnxVIv343^673 and annexin VI-b as AnxVIv1^
347. Annexin VI constructs were kindly supplied by
D. Voges and J. Benz (Martinsried, Germany).
2.2. Liposome sedimentation assay
Liposomes (80% phosphatidylserine, 20% phos-
phatidylcholine) (Avanti Polar Lipids) were incu-
bated at 22‡C for 60 min in 50 mM imidazole-HCl,
pH 7.0, 0.15 M NaCl, 1 mM MgCl2, 1 mM CaCl2,
1 mM dithiothreitol (DTT) (0.1 ml, ¢nal volume)
with 7 WM annexin VI plus or minus 11 WM
S100A1 or S100B. Mixtures were centrifuged at
85 000Ug for 30 min to separate supernatants from
pellets. Equal volumes of supernatants and pellets
were subjected to SDS-PAGE (10% acrylamide).
Gels were stained with Coomassie blue.
2.3. Fluorescence spectroscopy
S100A1, S100A1v88^93 or S100B was labeled
with acrylodan and characterized as reported
[45,46]. Samples of acrylodan-S100A1 or acrylodan-
S100A1v88^93 in 10 mM imidazole-HCl, pH 7.0,
1 mM MgCl2, 1 mM DTT, 0.1 M NaCl, 0.2 mM
EGTA plus approx. 100 WM free Ca2 were incu-
bated at 25‡C in the absence or presence of
S100A1, S100B, S100A1v88^9, annexin VI, annexin
VI-a, or annexin VI-b as described in the legend to
Figs. 2^4. Fluorescent emission spectra (excitation:
380 nm; emission: 400^650 nm) were recorded at
25‡C using a Perkin-Elmer LS 50 B spectro£uorom-
eter. Emission spectra were corrected for dilution
which never exceeded 5%.
2.4. Crosslinking experiments
For chemical crosslinking experiments, S100B,
S100A1 or S100A1v88^93 (8 WM) was incubated at
22‡C for 30 min in 10 mM imidazole-HCl, pH 7.4,
1 mM MgCl2, 1 mM DTT, 0.2 mM EGTA plus
approx. 100 WM free Ca2 (¢nal volume 0.1 ml) in
the absence or presence of 8 WM annexin VI, annexin
VI-a or annexin VI-b as described in the legend to
Fig. 5 prior to addition of the bifunctional cross-
linker disuccinimidyl suberate (DSS) (¢nal concen-
tration 0.5 mM). After incubation for 15 min at
room temperature, reactions were terminated by ad-
dition of 2% SDS (w/v) and 2% 2-mercaptoethanol
and samples analyzed by SDS-PAGE (10% acrylam-
ide). Separated peptides were transblotted onto nitro-
cellulose for Western blot analyses with a polyclonal
anti-S100A1/B antiserum (Dako, Denmark).
2.5. GFAP assembly assay
GFAP (10 WM) was assembled at 22‡C in 0.1 M
imidazole-HCl, pH 6.8, 1 mM DTT, 1 mM MgCl2,
1 mM EGTA (¢nal volume 0.1 ml) in the absence or
presence of 7.5 WM S100A1 or S100B [46] plus or
minus 15 WM annexin VI-a or annexin VI-b, in the
presence of approx. 100 WM free Ca2. Samples were
centrifuged to separate supernatants from pellets.
Equal volumes of supernatants and pellets were sub-
jected to SDS-PAGE (10% acrylamide). Gels were
stained with Coomassie blue.
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2.6. Vesicle preparation for in£ux and leakage assay
For practical reasons a geometric estimation of
lipid and protein surface was done. Taking the num-
bers from Reeves and Dowben [47], one obtains for a
lipid concentration of c(lipid) = 84 WM a vesicle con-
centration of 1N(ves) = 5.93108 ml31. The lipid
amount per vesicle, (lipid), can be calculated accord-
ing to




The total accessible lipid surface is dependent on the
amount of lipid present:
A  aUNves  aUnlipidUNA
X lipid 2
For n(lipid) = 0.1 Wmol this expression yields a sur-
face of A(lipid) = 8.2U1033 m2 with a(lipid) = 11.7
Wm2.
On the other hand, assuming a speci¢c surface of
a(Anx) = 28.9U106 m2/mol an amount of n(Anx) =
0.27 nmol (corresponding to a concentration of
c(Anx) = 0.5 WM) would have the same total protein
surface (A(Anx) = A(lipid)), if a monolayer of protein
is formed. Therefore, in samples containing 0.1 Wmol
lipid with a total volume of 500 Wl an annexin con-
centration of 0.5 WM would lead to complete lipid
surface covering under ideal conditions.
Phospholipid vesicles were prepared by mixing
phosphatidylserine (PS) and phosphatidylethanol-
amine (PE) (Avanti Polar Lipids) at a molar ratio
of 3:1 in CHCl3. The total amount of lipids used
was 1 Wmol resulting in ten aliquots with 0.1 Wmol
each. For the leakage assay 5(6)-carboxy£uores-
cein diacetate (Sigma, Deisenhofen) and for the
in£ux assay the pentasodium salt of FURA-2 (Cal-
biochem, San Diego, CA) was enclosed into the
vesicles.
2.7. Liposome stability assay (carboxy£uorescein
leakage assay)
Protein-induced leakage of phospholipid vesicles
was monitored by using carboxy£uorescein (CF) in
self-quenching concentrations enclosed into lipo-
somes. If leakage occurs, the £uorescence dye is
diluted into bu¡er A (200 WM EDTA, 180 mM sac-
charose, 10 mM HEPES, pH 7.4) and the £uores-
cence intensity increases [48]. The excitation wave-
length was set to 480 nm and the emission was
detected at 540 nm. To test the e¡ect of the di¡erent
proteins, at t = 5 min protein was added to a ¢nal
concentration of either 1 nM, 0.1 WM or 1 WM and
the £uorescence signal was recorded in 1 min inter-
vals. At t = 20 min the vesicles were disrupted by
addition of Triton X-100 (¢nal concentration




F20325 min3F034 min 3
where F is the emission intensity. N is normalized
with respect to a control measurement (N0) where
bu¡er was added instead of the protein aliquot.
From the resulting N/N03t relation the number at
t = 10 min was taken for comparisons.
2.8. Calcium in£ux assay (FURA-2 assay)
To investigate membrane permeabilization activity
a calcium in£ux assay based on previous reports was
used [49^51]. The calcium sensitive £uorescence dye
FURA-2 was enclosed in large unilamellar liposomes
and the protein-induced calcium in£ux was moni-
tored by a change in the £uorescence signal [52].
We expressively note that the assay was validated
by the above mentioned stability assay.
For an in£ux experiment a 20 Wl aliquot of
FURA-loaded liposome suspension was mixed with
475 Wl of bu¡er A and 5 Wl of a CaCl2 solution (50
mM). Fluorescence emission intensity was recorded
at 510 nm with excitation at 340 nm and 380 nm,
respectively, at time intervals of 1 min. After an
equilibration time of 4 min the protein was added
from a concentrated stock solution. At t = 36 min,
5 Wl of a solution of Br-A23187 (0.1 mg/ml) was
added to determine the maximal possible £uores-
cence signal. Intensity measurements were continued
until t = 40 min. Data analysis was performed by
normalizing the £uorescence ratio F340 nm/F380 nm
with respect to the maximal possible ratio obtained
from the values after addition of the ionophore (36^
40 min). The normalized £uorescence ratio f is plot-
ted against time, thereby yielding an in£ux curve into
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The activity parameter Q of each measurement was
normalized with respect to a control measurement
without protein (Q0).
2.9. Other procedures
The following molecular masses were applied: 21
kDa for the S100A1, S100B and S100A1v88^93
dimers, 50 kDa for GFAP, 72 kDa for annexin VI,
36 kDa for annexin VI-a and annexin VI-b. Free
Ca2 concentration was measured as described [53].
3. Results
3.1. Liposome sedimentation
S100A1 (Fig. 1) and S100B (not shown) did not
cosediment with liposomes irrespective of the pres-
ence or absence of Ca2 or annexin VI. Also, neither
S100 protein appeared to a¡ect the annexin VI bind-
ing to or cosedimentation with liposomes (Fig. 1).
No precipitation of either S100 protein or annexin
VI in the absence of liposomes was observed (not
shown). These data suggested that S100A1 and
S100B might not interact with the convex surface
of individual annexin VI lobes since it is known
that annexins interact with liposomes via their con-
vex surface [3,54]. Additionally, these results show
that S100A1 and S100B do not bind to liposome-
bound annexin VI.
Fig. 1. Annexin VI sedimentation with liposomes in the absence
or presence of S100A1. Annexin VI (7 WM) was incubated at
22‡C with liposomes (100 Wg) in a ¢nal volume of 0.1 ml in the
presence of 1 mM CaCl2 with or without 11 WM of S100A1.
Mixtures were centrifuged and supernatants (s) and pellets (p)
were analyzed by SDS-PAGE (10% acrylamide). Gels were
stained with Coomassie blue. Note that S100A1 does not cose-
diment with liposomes, irrespective of the presence or absence
of annexin VI. Identical results were obtained with S100B (not
shown). No precipitation of either S100 protein or annexin VI
in the absence of liposomes was observed (not shown).
Fig. 2. Fluorescence spectroscopic analysis of the interaction
of S100A1 with annexin VI, annexin VI-a, or annexin VI-b.
(A) Acrylodan-S100A1 (0.1 WM) was exposed to increasing con-
centrations of annexin VI in the absence or presence of 100 WM
free Ca2 as indicated. (B) Conditions were as in A, except that
acrylodan-S100A1 was sequentially exposed to increasing con-
centrations of annexin VI-a (A VI-a) and increasing concentra-
tions of annexin VI-b (A VI-b). (C) Conditions were as in B,
except that the order of addition was inverted. Results are
shown as wavelength of the £uorescence maximum (in nm) vs.
annexin concentration. Arrow in B and C indicates addition of
increasing concentrations of the second protein species (annexin
VI-b in B, and annexin VI-a in C).
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3.2. Fluorescence spectroscopy
Annexin VI and individual halves of annexin VI
(annexin VI-a or annexin VI-b) were analyzed for
their ability to a¡ect the conformation of S100A1,
S100B, and S100A1v88^93. Individual S100 proteins
were labeled with acrylodan, and experiments were
performed in the absence or presence of Ca2. Con-
formational changes in S100s were inferred from
changes in the £uorescence maximum of the emission
spectrum. Annexin VI caused a dose-dependent blue
shift of the £uorescence maximum of acrylodan-
S100A1 in the presence but not in the absence of
Ca2 (Fig. 2A). Qualitatively similar results were ob-
tained with S100B (not shown). Individual annexin
VI-a and annexin VI-b caused similar changes in the
£uorescence spectrum of acrylodan-S100A1 in the
presence of Ca2, i.e. an approx. 15 nm blue shift
of the £uorescence maximum (Fig. 2B and C, respec-
tively). However, whereas annexin VI-b did not in-
duce changes in £uorescence emission in the absence
of Ca2 (Fig. 2C), annexin VI-a caused a signi¢cant
blue shift (approx. 7 nm) under these conditions
(Fig. 2B). Also, the addition of increasing concentra-
tions of annexin VI-b to acrylodan-S100A1 previ-
ously exposed to annexin VI-a caused a further ap-
prox. 7 nm blue shift in the presence but not in the
absence of Ca2 (Fig. 2B), and similar results were
obtained in the reverse experiment in which increas-
ing concentrations of annexin VI-a were added to
acrylodan-S100A1 previously exposed to annexin
VI-b in the presence of Ca2 (Fig. 2C). In the ab-
sence of Ca2, annexin VI-a caused similar changes
in the £uorescence spectrum of acrylodan-S100A1
irrespective of the absence or presence of annexin
VI-b (Fig. 2B and C, respectively).
With acrylodan-S100B, annexin VI-a caused an
approx. 25 nm blue shift of the £uorescence maxi-
mum irrespective of the presence or absence of Ca2
or the absence or presence of annexin VI-b (Fig.
3A,B). In contrast, annexin VI-b-dependent changes
(approx. 7 nm blue shift) showed strict Ca2 depen-
dence and did not occur in the presence of annexin
VI-a (Fig. 3A,B).
We tentatively conclude that the C-terminal half of
annexin VI (annexin VI-b) is responsible for the
Ca2-dependent interaction of annexin VI to
S100A1 and S100B, that the annexin VI N-terminal
half also interacts with either S100 protein in the
absence of Ca2, and that individual halves of annex-
in VI apparently interact with non-identical regions
on either S100 protein.
No blue shift of the £uorescence maximum of
acrylodan-S100A1v88^93 could be detected on addi-
tion of increasing concentrations of annexin VI, irre-
spective of the absence or presence of Ca2 (Fig.
4A). Annexin VI-a caused a similar blue shift (ap-
prox. 9 nm) in the presence and in the absence of
Ca2 (Fig. 4B), whereas no changes were registered
in the case of annexin VI-b under the two conditions
(Fig. 4C). As in the case with acrylodan S100A1,
addition of annexin VI-a to acrylodan-S100A1v88^
93 previously exposed to annexin VI-b caused a sig-
ni¢cant (approx. 9 nm) blue shift of the £uorescence
maximum (Fig. 4C). In the reverse experiment we
con¢rmed the inability of annexin VI-b to a¡ect
the emission spectrum in the absence of Ca2, where-
as in the presence of Ca2 annexin VI-b caused fur-
Fig. 3. Fluorescence spectroscopic analysis of the interaction of
S100B with annexin VI-a or annexin VI-b. (A) Acrylodan-
S100B (0.1 WM) was exposed sequentially to increasing concen-
trations of annexin VI-a (A VI-a) and increasing concentrations
of annexin VI-b (A VI-b) in the absence or presence of 100 WM
free Ca2 as indicated. (B) Conditions were as in A, except that
the order of addition was inverted. Results are shown as wave-
length of the £uorescence maximum (in nm) vs. annexin con-
centration. Arrow in A and B indicates addition of increasing
concentrations of the second protein species (annexin VI-b in
A, and annexin VI-a in B).
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ther changes over those induced by annexin VI-a
(Fig. 4B). While the data shown in Fig. 4A would
suggest that the C-terminal extension of S100A1
might be critical for annexin VI binding, we suspect
that the apparent inability of annexin VI to a¡ect the
conformation of S100A1v88^93 might re£ect the
sum of two opposite events, one dependent on the
N-terminal half of annexin VI (annexin VI-a) and the
other one depending on the C-terminal half (annexin
VI-b). If so, each annexin VI half would interact with
a unique site on S100A1 and the annexin VI-a site
would not comprise the S100A1 C-terminal exten-
sion. Clearly, by the present experimental approach
we cannot exclude the possibility that e¡ects of an-
nexin VI-a on the emission spectrum of acrylodan-
S100A1v88^93 be the result of long range perturba-
tions. We can reasonably exclude the possibility that
lack of e¡ects of annexin VI and annexin VI-b on
acrylodan-S100A1v88^93 may depend on gross
changes in the S100A1 conformation due to deletion
of the C-terminal extension since S100A1v88^93 is
still a dimer and undergoes Ca2-induced conforma-
tional changes [18,20].
3.3. Crosslinking experiments
Chemical crosslinking was used to analyze further
the interaction of annexin VI, annexin VI-a and an-
nexin VI-b with S100A1, S100B and S100A1v88^93.
In the presence of Ca2, S100A1, S100B and
S100A1v88^93 equally interacted with annexin VI
(Fig. 5). Western blot analyses conducted with an
anti-S100A1/B antiserum showed that an approx.
78 kDa (1:1) annexin VI-S100 monomer complex
plus complexes of higher molecular mass correspond-
ing to various combinations of annexin VI and indi-
vidual S100 molecules formed following exposure of
mixtures of these proteins to DSS. Virtually no an-
nexin VI-S100 complexes could be detected in the
absence of Ca2 (Fig. 5). Annexin VI-a and annexin
VI-b also formed 1:1 as well as 1:2 complexes with
each S100 protein in the presence, but not absence of
Ca2 (Fig. 5). Data obtained with annexin VI-a by
the chemical crosslinking approach were at variance
with those obtained by £uorescence spectroscopy,
suggesting the possibility that Ca2 is required for
stabilization of the annexin VI-a/S100 complex, but
not for annexin VI-a to interact with any of the S100
proteins tested in the present work. TRTK-12 only
caused a slight reduction of the extent of annexin VI,
annexin VI-a and annexin VI-b interaction with
S100A1, S100B, and S100A1v88^93 (not shown), in
agreement with the observation that occupation of
the annexin VI site(s) perturbed the desmin/GFAP/
TRTK-12 site on each of the above S100 protein [24]
without any obvious competition.
Fig. 4. Fluorescence spectroscopic analysis of the interaction of
S100A1v88^93 with annexin VI, annexin VI-a, or annexin VI-b.
(A) Acrylodan-S100A1v88^93 (0.1 WM) was exposed to increas-
ing concentrations of annexin VI in the absence or presence of
100 WM free Ca2 as indicated. (B) Conditions were as in A,
except that acrylodan-S100A1 was sequentially exposed to in-
creasing concentrations of annexin VI-a (A VI-a) and increasing
concentrations of annexin VI-b (A VI-b). (C) Conditions were
as in B, except that the order of addition was inverted. Results
are shown as wavelength of the £uorescence maximum (in nm)
vs. annexin concentration. Arrow in B and C indicates addition
of increasing concentrations of the second protein species (an-
nexin VI-b in B, and annexin VI-a in C).
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Fig. 6. E¡ects of annexin VI-a and annexin VI-b on S100A1-
dependent inhibition of GFAP intermediate ¢lament formation.
GFAP (10 WM) was assembled as described in Section 2 in the
absence (lanes a,b) or presence (lanes c,d) of 7.5 WM S100A1
plus 15 WM annexin VI-a (A VI-a) or 15 WM annexin VI-b (A-
VI-b). After 60 min at 30‡C, mixtures were centrifuged. Identi-
cal volumes of supernatants (s) and pellets (p) were subjected
to SDS-PAGE (10% acrylamide). Gels were stained with Coo-
massie blue. Note that S100A1 inhibits the formation of GFAP
IFs (lanes c,d) and that annexin VI-b (lanes g,h) but not annex-
in VI-a (lanes e,f) blocks the inhibitory e¡ect of S100A1. The
positions of GFAP, annexin VI-a or annexin VI-b, and S100A1
monomer are indicated by an arrowhead, an asterisk and an ar-
row, respectively. The sign + indicates the presence of the perti-
nent protein species.
Fig. 5. Interaction of S100A1, S100A1v88^93, or S100B with
annexin VI, annexin VI-a, or annexin VI-b as investigated by
chemical crosslinking. (A) S100A1 (8 WM) was incubated for 30
min at 22‡C with 8 WM annexin VI (A VI) (lanes c,d), annexin
VI-a (A VI-a) (lanes e,f), or annexin VI-b (A VI-b) (lanes g,h)
in the presence (lanes c,e,g) or absence (lanes d,f,h) of 100 WM
free Ca2. S100A1 was incubated as above in the absence of
annexin and Ca2 (lane b). DSS was then added to mixtures to
0.5 mM for 15 min. Samples were subjected to SDS-PAGE
(10% acrylamide) and separated polypeptide electroblotted onto
nitrocellulose paper for Western blotting with an anti-S100A1/B
antiserum. Lane a contains molecular weight markers (M).
(B) Conditions were as in A, except that S100A1v88^93 was
used. (C) Conditions were as in A, except that S100B was used.
Note the Ca2-dependent formation of complexes between
S100A1, S100A1v88^93, or S100B and each of the annexins
tested. The sign + indicates the presence of the pertinent reac-
tant in the reaction mixture.
6
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3.4. Annexin VI-b, but not annexin VI-a, blocks the
ability of S100A1 or S100B to inhibit GFAP
assembly
Previous work has shown that annexin VI, but not
annexin V, reduces the inhibitory e¡ect of S100A1
and S100B on the assembly of GFAP and desmin
into their respective IFs [24]. We thus tested individ-
ual halves of annexin VI as potential inhibitors of
S100A1 or S100B e¡ects on GFAP assembly. As
shown in Fig. 6, annexin VI-b, but not annexin VI-
a, reduced the ability of S100A1 to inhibit GFAP
assembly as investigated by a sedimentation assay.
Similar results were obtained with S100B (not
shown). These data support the conclusion that an-
nexin VI uses its C-terminal half (annexin VI-b) to
Table 2
Activity parameters obtained by the calcium in£ux assay with di¡erent annexin/S100 combinations
Protein c (nM) Q/Q0 (nM) c (1031 WM) Q/Q0 (1031 WM) c (WM) Q/Q0 (WM)
Control ^ 1.0 ^ 1.0 ^ 1.0
A V 2.2 0.42 0.8 11 0.8 9.2
A VI 0.9 5.1 1.1 5.2 1.0 13
A VI-a 3.8 0.35 1.0 2.4 1.0 13
A VI-b 2.2 0.56 1.1 2.9 0.8 4.4
S100A1 1.7 0.21 1.2 7.1 1.2 54
S100B 3.3 0.58 1.2 3.8 1.2 26
A V/S100A1 2.2/1.7 0.64 0.8/1.2 8.9 0.8/1.2 18
A V/S100B 2.2/3.3 0.28 0.8/1.2 1.7 0.8/1.2 6.7
A VI/S100A1 0.9/1.7 0.50 1.1/1.2 8.3 1.0/1.2 7.9
A VI/S100B 0.9/3.3 10.1 1.1/1.2 7.2 1.0/1.2 7.8
A VI-a/S100A1 3.8/1.7 0.86 1.0/1.2 1.9 1.0/1.2 8.0
A VI-a/S100B 3.8/3.3 0.41 1.0/1.2 2.9 1.0/1.2 34
A VI-b/S100A1 2.2/1.7 0.65 1.1/1.2 2.0 0.8/1.2 2.7
A VI-b/S100B 2.2/3.3 0.55 1.1/1.2 1.9 0.8/1.2 6.6
The numbers shown represent the average of at least two measurements. The control measurement was done in the presence of 500
WM CaCl2 in bu¡er A.
Table 1
Liposome stability parameters obtained with the carboxy£uorescein leakage assay
Protein c (nM) N/N0 (nM) c (1031 WM) N/N0 (1031 WM) c (WM) N/N0 (WM)
Control ^ 1.0 ^ 1.0 ^ 1.0
A V 2.3 0.13 0.8 1.1 0.8 0.31
A VI 0.8 1.2 1.1 0.61 1.0 0.31
A VI-a 3.9 0.12 1.0 1.2 1.0 0.19
A VI-b 2.2 1.1 1.1 0.95 0.8 0.34
S100A1 1.7 1.3 1.2 0.69 1.2 0.26
S100B 3.3 1.4 1.2 1.1 1.2 0.29
A V/S100A1 2.3/1.7 0.14 0.8/1.2 0.92 ^ ^
A V/S100B 2.3/3.3 0.33 0.8/1.2 0.17 ^ ^
A VI/S100A1 ^ ^ 1.1/1.2 0.72 ^ ^
A VI/ 100B 0.8/3.3 1.2 1.1/1.2 1.0 ^ ^
A VI-a/S100A1 ^ ^ 1.0/1.2 1.0 ^ ^
A VI-a/S100B ^ ^ 1.0/1.2 0.86 ^ ^
A VI-b/S100A1 2.2/1.7 2.0 1.1/1.2 0.88 ^ ^
A VI-b/S100B 2.2/3.3 1.1 1.1/1.2 0.99 ^ ^
Numbers are averages of at least two measurements. The control experiment was done in the presence of 500 WM CaCl2 in bu¡er A.
Values lower than 1.0 indicate liposome stabilization due to a reduced dye leakage.
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modulate S100A1 and S100B e¡ects on IF assembly,
and that annexin VI-a and annexin VI-b bind to
distinct sites on either S100 protein.
3.5. Carboxy£uorescein leakage assay
The e¡ect of S100A1 and S100B and annexin VI,
annexin VI-a and annexin VI-b on the stability of
PS:PE (3:1) liposomes was investigated using the
CF leakage assay (Table 1). Annexin V was also
tested in these experiments given its ability to interact
with the two S100 proteins [24]. Stability parameters
N/No of 1 indicate no e¡ects, whereas values greater
than 1 indicate destabilization of the liposome
vesicles. At 0.1 WM protein concentration, no signi¢-
cant e¡ect of either protein or protein mixture (with
the exception of the combination annexin V/S100B)
was observed. Surprisingly, this behavior was not
true for the annexin V/S100B mixture, which led to
a considerable stabilization of the vesicles. At 1 WM
protein concentration only the individual proteins
were tested and moderate stabilization was found
for all of them.
The control experiment in the absence of Ca2,
which displayed a low stability parameter, indicated
that calcium ions per se destabilized the liposome
vesicles. This agrees with previous observations
[48]. It is of interest that neither protein destabilizes
the vesicles at 1 WM concentration. This result vali-
dates the activity parameters obtained in the calcium
in£ux assay (see below) as the latter e¡ect is due to a
Ca2 in£ux into liposomes and not caused by leak-
age of the FURA-2 dye into solution.
3.6. Calcium in£ux assay
Prior to testing mixtures of annexin/S100 proteins
every protein was measured in the calcium in£ux
assay on its own to characterize its e¡ect on PS:PE
(3:1) liposomes loaded with FURA-2. Based on the
geometric estimation of protein and total lipid sur-
face, three concentration levels of protein were tested
(1 nM, 0.1 WM, and 1 WM).
Surprisingly, S100A1 and S100B caused a consid-
erable Ca2 in£ux into liposomes when tested at
1 WM (Table 2). The in£ux activity under these con-
ditions was four times (S100A1) and two times
(S100B) higher than for annexin V. Any combination
Fig. 7. Results of calcium in£ux experiments with di¡erent an-
nexins and S100 proteins. Q values obtained as described in Sec-
tion 2 are normalized with respect to a sample without protein
(Q0). The control activity (background of the assay) appears
therefore at Q/Q0 = 1. (A) Calcium in£ux activities of individual
proteins dependent on the protein concentration. All annexins
except for annexin VI show a dose-dependent behavior. Note
that both S100 proteins are able to permeabilize the membrane
themselves with the activity being in the same range as ob-
served for annexin proteins. (B) Calcium in£ux activities of pro-
tein mixtures annexin/S100A1. The activities of annexins V, VI-
a and VI-b at 0.1 WM concentration level is decreased when
compared to the results of individual proteins. The annexin VI
activity at the same concentration level is unchanged. For an-
nexin VI at 1 nM concentration the presence of the S100 pro-
tein leads to a decrease in activity by one order of magnitude.
(C) Calcium in£ux activities of protein mixtures annexin/S100B.
Results are basically the same as with S100A1 (cf. B). However,
annexin VI activity at 1 nM concentration level is increased by
one order of magnitude thereby reaching again the value from
the individual measurement (cf. A).
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of either S100 protein with the di¡erent annexins
lowered the in£ux activity of the former (6^30%),
except for the combination of S100B with annexin
VI-a. In the latter mixture the activity of S100B
was restored.
The concentration dependence of Ca2 in£ux ac-
tivity as measured with this assay showed a linear
correlation between the normalized activity and the
protein concentration in a double logarithmic plot
(see Fig. 7). However, the di¡erence in activities of
the measured proteins at a particular concentration
level was not signi¢cant when compared to each oth-
er. The only exceptions were the combinations an-
nexin V/S100A1 and annexin VI-a/S100B. Consider-
ing annexin/S100 interaction, we obtained three
remarkable results. (i) At 0.1 WM protein concentra-
tion, the activity of annexin V in combination with
either S100A1 or S100B was much lower than that
for the annexin itself. Activity was even lower than
for the individual S100 proteins. The same holds for
the 1 WM level in the case of S100B, but not for the
mixture with S100A1. (ii) In£ux activity induced by
annexin VI was nearly independent of the protein
concentration used (individual measurements and in
combination with S100B). However, the mixture an-
nexin VI/S100A1 showed signi¢cantly lowered activ-
ity at the 1 nM level. (iii) Either S100 protein, except
for the annexin VI-a/S100B protein combination at
the 1 WM level, did not a¡ect annexins VI-a and VI-
b.
4. Discussion
There is growing evidence that some annexins in-
teract with some members of the S100 protein family
(for reviews see [2,6]). In several cases functional
correlates of these interactions have been described
[24,34,35]. Recently, we reported that annexin VI
and annexin V interact with S100A1 and S100B,
and that annexin VI, but not annexin V, blocks the
ability of S100A1 and S100B to inhibit the assembly
of GFAP and desmin into their respective IFs [24].
These preliminary data also suggested that annexin
VI binds to a site on either S100 protein non-identi-
cal to the desmin/GFAP site. In the present work we
analyzed further the interaction between annexin VI
and S100A1 and S100B to get additional information
about some structural aspects of these interactions
and performed functional assays. Also, we extended
our investigations to annexin V/S100A1 or S100B
interactions for comparison.
4.1. Evaluation of binding properties
Chemical crosslinking experiments indicate that
the C-terminal extension of S100A1 (and, by analo-
gy, S100B) is not required for the interaction of ei-
ther S100 protein with annexin VI or individual
halves of annexin VI, and that these interactions
are Ca2-dependent. On the other hand, previous
work has shown that deletion of the C-terminal ex-
tension abolishes the ability of S100A1 to interact
with a number of known S100A1 and S100B target
proteins, including GFAP, by the same experimental
approach [20]. In contrast, £uorescence spectroscopy
data indicate that, whereas annexin VI and annexin
VI-b cause each a relocation of Cys85 (in S100A1)
and Cys84 (in S100B) in a less polar environment in
the presence of Ca2, annexin VI-a-induced changes
occurs independently of the presence or absence of
Ca2. Also, annexin VI-a causes a relocation of
Cys85 in S100A1v88^93 in a less polar environment
independently of Ca2, whereas annexin VI and an-
nexin VI-b cause no shifts of the emission maximum
of the £uorescence spectrum of acrylodan-
S100A1v88^93 irrespective of the absence or pres-
ence of Ca2. Moreover, annexin VI-a and annexin
VI-b cause independent changes in the S100A1 and
S100B conformation in the presence of Ca2 when
added sequentially to each of these proteins, inde-
pendently of the order of additions. Together, our
£uorescence data suggest that helix IV in S100A1
and S100B, where the relevant Cys is located, might
participate either directly or indirectly in the recog-
nition of annexin VI and annexin VI-b, provided
S100A1 and S100B are in their Ca2-loaded confor-
mation and their C-terminal extension is present,
whereas helix IV seems to be a¡ected by annexin
VI-a irrespective of the absence or presence of
Ca2 and the S100A1 (and, by analogy, S100B)
C-terminal extension.
The combination of chemical crosslinking and
£uorescence spectroscopy data presented here sug-
gests that: (i) the annexin VI site on S100A1 and
S100B does not completely overlap the desmin/
BBAMCR 14680 27-11-00 Cyaan Magenta Geel Zwart
M. Garbuglia et al. / Biochimica et Biophysica Acta 1498 (2000) 192^206202
GFAP site; (ii) the C-terminal extension of S100A1
(and, by analogy, S100B) is not critical for annexin
VI binding to either S100 protein; and (iii) individual
halves of the bilobed annexin VI molecule interact
with di¡erent regions of S100A1 or S100B. Also, the
contrast between the Ca2 dependence of complex
formation of annexin VI-a with each S100 protein
as detected by chemical crosslinking, and the Ca2
independence of annexin VI-a binding as detected by
£uorescence spectroscopy probably stands on di¡er-
ences in Ca2 requirements for annexin VI-a binding
to each S100 protein and stabilization of annexin VI-
a/S100 complexes. These observations give some in-
dication about the regions of S100 protein that might
be implicated in the annexin VI binding. Structural
information indicates that residues in helix II, the
hinge region, helix III, helix VI, and the C-terminal
extension, in one S100 monomer, and residues in
helix I in the other monomer of an S100 dimer par-
ticipate in target recognition in the presence of Ca2
[12,15^23]. One possibility is that the individual re-
gions mentioned above might be implicated to a larg-
er or a smaller extent in target recognition depending
on the S100 protein and the target protein considered
[15,18^20,23,55]. Our present data suggest that resi-
dues in the S100B and S100A1 regions that become
exposed to the solvent upon Ca2 binding [9,12,14]
are important for the recognition of annexin VI, an-
nexin VI-a and annexin VI-b, but residues in the
S100 C-terminal extension have no roles in this ac-
tivity. Thus, we propose that individual halves of
annexin VI bind to distinct sites on the S100A1 or
S100B, and that two copies of the bilobed annexin
VI molecule wrap around an S100A1 or S100B ho-
modimer (as inferred by the detection of 1:1 and 2:2
complexes of each S100 protein with annexin VI, and
1:1 complexes of each S100 protein with annexin VI-
a, or annexin VI-b, by chemical crosslinking). A pu-
tative model of the (annexin VI-S100A1 or S100B)2
heterotetramer is shown in Fig. 8. At present, we do
not know whether regions of both S100 monomers
participate in the binding of annexin VI, and conclu-
sions on whether the two annexin VI lobes bind S100
protein simultaneously await further experimenta-
tion.
4.2. Evaluation of functional properties
Annexin VI-b, but not annexin VI-a, reduces the
ability of S100A1 or S100B to inhibit the assembly of
GFAP. This observation suggests that the two halves
of annexin VI are not equivalent, nor are they inter-
changeable. This represents further evidence for dif-
ferent structural requirements of each half of annexin
VI binding to either S100 protein.
Annexin-S100 interaction becomes more compli-
cated when a phospholipid membrane as a third
partner comes into play. Results obtained in the
present study show clearly that S100A1 and S100B
do not bind to annexin VI in the membrane-bound
state. Supposedly, this is due to an altered conforma-
tion of annexin VI when bound to a lipid surface
[3,54,56]. Although there are no major rearrange-
ments of annexins upon binding to membranes
[57,58], there are certainly other conformations
adopted than in solution. This is also supported by
the ¢nding that annexin III/annexin V £uorescence
quenching by DMSO is di¡erent in solution and in
the membrane-bound state [51]. Also, annexins III
and V show only weak binding of BDA753, a steri-
cally extended benzodiazepine derivative, but the
binding is greatly enhanced in the membrane-bound
state [51].
The interaction of annexins with S100 proteins as
investigated by the CF leakage assay does not cause
liposome destabilization, whereas the Ca2 in£ux as-
say indicates that individual S100 proteins or annex-
ins V or VI, respectively, are able to permeabilize the
liposome membrane. Certain combinations of S100s
with annexins, on the other hand, display reduced
in£ux activity. There are two possible explanations:
Fig. 8. Putative model of annexin VI complexation with
S100A1 or S100B in solution. Two copies of annexin VI (in
magenta) would wrap around an S100A1 or S100B dimer (in
yellow).
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(i) annexin protects the membrane bilayer against the
permeabilizing e¡ect of the S100s by binding to and
covering the membrane surface (and vice versa the
S100s protect against destabilization by annexins);
and (ii) a complex between annexin and S100 protein
is formed that shows no permeabilizing activity.
Hypothesis (i) would assume that all annexins
show the same behavior in combination with S100
proteins since the supposed e¡ect of S100 and annex-
in interaction would not be of speci¢c nature. On the
other hand, with hypothesis (ii) di¡erences in the
behavior of di¡erent annexins are possible, when
mixed with S100 proteins.
There is indeed di¡erence in annexin activities as
mentioned in Section 3. Particularly interesting are
the results obtained with annexin VI-S100 combina-
tions. When comparing the concentration depen-
dence of Ca2 in£ux activity Q/Q0 for the di¡erent
protein mixtures, annexin VI shows a unique behav-
ior. Tested as an individual protein, annexin VI ac-
tivity does not vary with the concentration in a dou-
ble-logarithmic plot. Even at very low concentrations
(e.g. 1 nM), annexin VI shows the same activity as at
higher concentrations. The same behavior is ob-
served in combination with S100B, but not when
mixed with S100A1. As the absolute activities of an-
nexin VI and annexin VI/S100B are very similar,
there is reason to believe that this activity is due to
annexin VI. Apparently, only small amounts of an-
nexin VI (approx. 1 nM) are su⁄cient to induce
Ca2 in£ux activities of Q/Q0W5. Accordingly, the
activity of the combination annexin VI/S100A1,
showing a signi¢cantly reduced activity at 1 nM,
gives reason to believe that there is a speci¢c inter-
action between these two proteins. At increased pro-
tein concentrations there is probably enough annexin
VI left to perform in£ux activity, resulting in a ‘re-
stored’ annexin VI activity as seen in Fig. 6. Also,
from the reduced activity displayed by annexin V in
combination with either S100 protein, a speci¢c in-
teraction between this annexin and S100A1 and
S100B can be postulated.
However, it has to be mentioned again that there
is a considerable in£ux activity caused by both S100
proteins individually, and this activity is decreased in
combination with any annexin. In the absence of
speci¢c S100-annexin interactions it seems likely
that this e¡ect is due to protection by annexins
bound to liposomes, which prevents the permeabiliz-
ing activity of S100 proteins. In summary there
seems to be a superimposition of both hypotheses
mentioned above, which complicates straightforward
conclusions from these results. In this context,
although there is evidence for interaction of S100B
with liposomes and S100B-induced changes in the
structure of lipid bilayers [59^63], S100B and
S100A1 do not cosediment with liposomes. Actually,
S100B was shown to reduce the Ca2-dependent ten-
dency of liposomes to aggregate and fuse [62], which
points to a di¡erent mode of interaction of annexins
and S100A1 and S100B with lipid bilayers.
4.3. Conclusions
Collectively, our data indicate that S100A1 homo-
dimers and S100B homodimers interact with annexin
VI thereby forming (annexin VI-S100A1 or S100B)2
heterotetramers in the presence of Ca2, and that the
C-terminal half is responsible for the reported block-
ing activity of annexin VI toward the inhibitory ef-
fects of each S100 protein on the polymerization of
desmin and GFAP into their respective IFs [24]. Our
data also suggest that individual halves of annexin
VI bind to unique sites on S100A1 or S100B, and
that the sites of interaction of annexin VI do not
completely overlap the desmin/GFAP site on each
S100 protein. Since annexin VI and individual annex-
in VI halves bind equally to S100A1, S100B and
S100A1v88^93, we conclude that annexin VI inter-
acts with regions of the above binding surface other
than the C-terminal extension. Also, our data are
consistent with the possibility that two copies of an-
nexin VI wrap around an S100A1 or S100B homo-
dimer (Fig. 8), and that the ability of annexin VI to
block the inhibitory e¡ect of each S100 protein on IF
subunit assembly [24] may depend on annexin VI
interaction with residues in the S100A1/B hinge re-
gion, helix III or helix IV. Based on the 3D structure
of Ca2-loaded S100B [9,12,14], we speculate that
e¡ects of annexin VI on either S100 protein might
be explained by the binding of annexin VI-b to helix
IV and the hinge region ^ H ^ in one S100 monomer
(and IVP and HP in the other monomer). Since an-
nexin VI-a also binds each of the three S100 protein
species used in the present study, yet without block-
ing the e¡ects of S100A1 or S100B on GFAP assem-
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bly, we also anticipate that annexin VI-a interacts
with a surface of each S100 monomer on the side
of helix I (IP in the other monomer) (i.e., an annexin
VI molecule would clamp an S100 monomer from
the N-terminal side of the S100 molecule). In this
case, the C-terminal extension would still be free to
interact with the N-terminal head of desmin or
GFAP [20,38,64]. However, occupation of the hinge
region by annexin VI-b would render the interaction
of the S100 with the IF subunit less stable, with
consequent detachment of two interacting species
under IF assembly conditions and restoration of IF
subunit assembly competence. Studies of annexin VI
interaction with S100s mutated in the hinge region
and helix IV should enable us to verify or deny the
above hypothesis. The envisaged mode of interaction
of annexin VI with S100A1 or S100B di¡ers from the
mode of interaction of annexin II with its partner
S100 protein (S100A10) [15], and of annexin I with
its partner S100 protein (S100A11) [23]. In these
cases, the S100 C-terminal region proved critical
for the recognition of the partner annexin. Also, in
these cases the annexin N-terminal domain has been
shown to be the moiety implicated. However, in the
case of the annexin XI-S100A6 interaction, helix I of
S100A6 was reported to be essential for the recogni-
tion of the partner annexin [65,66], and helix I of
S100A11 was shown to be important as well in the
recognition of annexin I [21]. Thus, there is a variety
of modes of interaction of members of the S100 pro-
tein family with members of the annexin family.
A con¢rmation of S100A1 and S100B interaction
with annexin VI comes from our data on e¡ects of
each S100 protein on annexin VI Ca2 in£ux activity.
In fact, annexin VI displays a reduced Ca2 in£ux
activity in the presence of either S100 protein. The
same applies to annexin V, pointing to a speci¢c
interaction of each S100 protein with this annexin
as well. Yet, neither S100 protein cosediments with
annexin VI in a liposome sedimentation assay, sug-
gesting that the conformation assumed by annexin
VI in the liposome-bound state is unfavorable for
S100A1 or S100B binding. This would indicate that
any Ca2-dependent interaction of S100A1 or S100B
with annexin VI would occur in the cytoplasm. How-
ever, we cannot exclude that at those membrane sites
where annexin VI and S100A1 or S100B concentrate
[40,67^69], these proteins may a¡ect each other’s ac-
tivities by, for instance, interacting with each other
while being bound to unique membrane sites. The
dimeric nature of S100A1 and S100B and the bilobed
nature of annexin VI could render this event possi-
ble.
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